Drug Enforcement Administration April 2018 – Federal Register Recent Federal Regulation Documents

Garrett Howard Smith, M.D.; Decision and Order
Document Number: 2018-09020
Type: Notice
Date: 2018-04-30
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Cayman Chemical Company
Document Number: 2018-08348
Type: Notice
Date: 2018-04-23
Agency: Drug Enforcement Administration, Department of Justice
Schedules of Controlled Substances: Placement of Butyryl Fentanyl and U-47700 Into Schedule I
Document Number: 2018-08280
Type: Rule
Date: 2018-04-20
Agency: Drug Enforcement Administration, Department of Justice
With the issuance of this final order, the Administrator of the Drug Enforcement Administration maintains the placement of the substances butyryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- phenylbutanamide) and U-47700 (3,4-dichloro-N-[2- (dimethylamino)cyclohexyl]-N-methylbenzamide), including their isomers, esters, ethers, salts, and salts of isomers, esters and ethers, in schedule I of the Controlled Substances Act. This scheduling action discharges the United States obligations under the Single Convention on Narcotic Drugs (1961). This action continues to impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, import, export, engage in research or conduct instructional activities with, or possess), or propose to handle, butyryl fentanyl and U-47700.
Controlled Substances Quotas
Document Number: 2018-08111
Type: Proposed Rule
Date: 2018-04-19
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration (DEA) is publishing this proposed rule to strengthen controls over diversion of controlled substances and make other improvements in the quota management regulatory system for the production, manufacturing, and procurement of controlled substances.
Importer of Controlled Substances Application: Clinical Supplies Management Holdings, Inc.
Document Number: 2018-07978
Type: Notice
Date: 2018-04-17
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Registration
Document Number: 2018-07455
Type: Notice
Date: 2018-04-11
Agency: Drug Enforcement Administration, Department of Justice
Registrants listed below have applied for and been granted registration by the Drug Enforcement Administration (DEA) as bulk manufacturers of various classes of schedule I and II controlled substances.
Witold Marek Zajewski, M.D.; Decision and Order
Document Number: 2018-07454
Type: Notice
Date: 2018-04-11
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Registration
Document Number: 2018-07444
Type: Notice
Date: 2018-04-11
Agency: Drug Enforcement Administration, Department of Justice
Registrants listed below have applied for and been granted registration by the Drug Enforcement Administration (DEA) as importers of various classes of schedule I or II controlled substances.
Importer of Controlled Substances Application: Lipomed
Document Number: 2018-07442
Type: Notice
Date: 2018-04-11
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Almac Clinical Services Incorp (ACSI)
Document Number: 2018-07441
Type: Notice
Date: 2018-04-11
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: United States
Document Number: 2018-07167
Type: Notice
Date: 2018-04-09
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: AMRI Rensselaer, Inc.
Document Number: 2018-07165
Type: Notice
Date: 2018-04-09
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Catalent Pharma Solutions, LLC
Document Number: 2018-06872
Type: Notice
Date: 2018-04-04
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Wildlife Laboratories Inc.
Document Number: 2018-06871
Type: Notice
Date: 2018-04-04
Agency: Drug Enforcement Administration, Department of Justice
Mehdi Nikparvarfard, M.D.; Decision and Order
Document Number: 2018-06870
Type: Notice
Date: 2018-04-04
Agency: Drug Enforcement Administration, Department of Justice
Angela L. Lorenzo, P.A.: Decision and Order
Document Number: 2018-06618
Type: Notice
Date: 2018-04-02
Agency: Drug Enforcement Administration, Department of Justice
Bernard Wilberforce Shelton, M.D.; Decision and Order
Document Number: 2018-06617
Type: Notice
Date: 2018-04-02
Agency: Drug Enforcement Administration, Department of Justice